首页 | 期刊导航 | 学习空间 | 退出

期刊文章列表

  • Nur Farah Meor Azlan,Maarten P.Koeners,Jinwei Zhang(Institute of Biomedical and Clinical Sciences,Medical School,College of Medicine and Health,University of Exeter,Hatherly Laboratories).Regulatory control of the Na-Cl co-transporter NCC and its therapeutic potential for hypertension[J].Acta Pharmaceutica Sinica B,2021,第5期
  • Shaoyong Lu1,2,Yingyi Chen1,Jiacheng Wei1,Mingzhu Zhao2,Duan Ni3,Xinheng He1,Jian Zhang1,2(Department of Pathophysiology,Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education,Shanghai Jiao Tong University,School of Medicine;State Key Laboratory of Oncogenes and Related Genes,Renji Hospital,Shanghai Jiao Tong University,School of Medicine;The Charles Perkins Centre,University of Sydney).Mechanism of allosteric activation of SIRT6 revealed by the action of rationally designed activators[J].Acta Pharmaceutica Sinica B,2021,第5期
  • Peng Gao1,2,Xin Chang3,Dagan Zhang1,2,Yafei Cai4,Gen Chen5,Hao Wang6,Tianfu Wang1(Guangdong Key Laboratory of Biomedical Measurements and Ultrasound Imaging,Department of Biomedical Engineering,Shenzhen University;State Key Laboratory of Bioelectronics,School of Biological Science and Medical Engineering,Southeast University;Key Laboratory of Biomedicine in Gene Diseases and Health of Anhui Higher Education Institutes,College of Life Sciences,Anhui Normal University;College of Animal Science and Technology,Nanjing Agricultural University;School of Materials Science and Engineering,Central South University;College of Energy,Soochow Institute for Energy and Materials Innovations and Key Laboratory of Advanced Carbon Materials and Wearable Energy Technologies of Jiangsu Province,Soochow University).Synergistic integration of metal nanoclusters and biomolecules as hybrid systems for therapeutic applications[J].Acta Pharmaceutica Sinica B,2021,第5期
  • Fen Long1,Di Yang1,Jinghua Wang1,Qing Wang1,Ting Ni2,Gang Wei2,Yizhun Zhu3,Xinhua Liu1(Pharmacophenomics Laboratory,Human Phenome Institute,Fudan University;State Key Laboratory of Genetic Engineering & MOE Key Laboratory of Contemporary Anthropology,Collaborative Innovation Center of Genetics and Development,School of Life Sciences and Shanghai Cancer Center,Fudan University;State Key Laboratory of Quality Research in Chinese Medicine and School of Pharmacy,Macau University of Science and Technology).SMYD3-PARP16 axis accelerates unfolded protein response and mediates neointima formation[J].Acta Pharmaceutica Sinica B,2021,第5期
  • Hassan Dana1,Ghanbar Mahmoodi Chalbatani2,3,Seyed Amir Jalali3,Hamid Reza Mirzaei2,Stephan A.Grupp4,Eloah Rabello Suarez5,Catarina Rap?so6,Thomas J.Webster7(Cancer Research Center,Cancer Institute of Iran,Tehran University of Medical Sciences;Department of Medical Immunology,School of Medicine,Tehran University of Medical Sciences;Department of Immunology,School of Medicine,Shahid Beheshti University of Medical Sciences;Division of Oncology,Department of Pediatrics,the Children’s Hospital of Philadelphia;Center for Natural and Human Sciences,Federal University of ABC;Faculty of Pharmaceutical Sciences,State University of Campinas (UNICAMP);Department of Chemical Engineering,Northeastern University).CAR-T cells:Early successes in blood cancer and challenges in solid tumors[J].Acta Pharmaceutica Sinica B,2021,第5期
  • Seyed Hossein Kiaie1,2,Mohammad Javad Sanaei3,Masoud Heshmati3,Zahra Asadzadeh1,Iman Azimi4,Saleh Hadidi5,Reza Jafari6,7,Behzad Baradaran1(Immunology Research Center,Tabriz University of Medical Sciences;Nano Drug Delivery Research Center,Kermanshah University of Medical Sciences;Cellular and Molecular Research Center,Basic Health Sciences Institute,Shahrekord University of Medical Sciences;School of Pharmacy and Pharmacology,College of Health and Medicine,University of Tasmania;Clinical Biochemistry Research Center,Basic Health Sciences Institute,Shahrekord University of Medical Sciences;Solid Tumor Research Center,Cellular and Molecular Medicine Institute,Urmia University of Medical Sciences;Department of Immunology and Genetics,School of Medicine,Urmia University of Medical Sciences).Immune checkpoints in targetedi-mmunotherapy of pancreatic cancer:New hope for clinical development[J].Acta Pharmaceutica Sinica B,2021,第5期
  • Editoral Office of Acta Pharmaceutica Sinica(Editoral Office of Acta Pharmaceutica Sinica).Information for Authors[J].Acta Pharmaceutica Sinica B,2021,第5期
  • Qingqing Xiao1,Xiaotong Li1,Yi Li1,Zhenfeng Wu2,Chenjie Xu3,Zhongjian Chen4,Wei He4,1(School of Pharmacy,China Pharmaceutical University;Key Laboratory of Modern Preparation of TCM,Ministry of Education,Jiangxi University of Traditional Chinese Medicine;Department of Biomedical Engineering,City University of Hong Kong;Shanghai Skin Disease Hospital,Tongji University School of Medicine).Biological drug and drug delivery-mediated immunotherapy[J].Acta Pharmaceutica Sinica B,2021,第4期
  • Iara Maíra de Oliveira Viana1,2,Sabrina Roussel2,Joan Defrêne3,Eliana Martins Lima1,Frédéric Barabé3,Nicolas Bertrand2(Laboratory of Pharmaceutical Technology (FarmaTec),Federal University of Goiás;Faculty of Pharmacy,Université Laval and CHU de Québec-Université Laval Research Center;Department of Medicine,Faculty of Medicine,Université Laval and CHU de Québec-Université Laval Research Center).Innate and adaptive immune responses toward nanomedicines[J].Acta Pharmaceutica Sinica B,2021,第4期
  • Canyu Yang1,Bing He2,3,Wenbing Dai2,Hua Zhang2,Ying Zheng4,Xueqing Wang1,2,Qiang Zhang1,2,3(Department of Pharmacy Administration and Clinical Pharmacy,School of Pharmaceutical Science,Peking University;Beijing Key Laboratory of Molecular Pharmaceutics,New Drug Delivery Systems,School of Pharmaceutical Sciences,Peking University;State Key Laboratory of Natural and Biomimetic Drugs,Peking University;State Key Laboratory of Quality Research in Chinese Medicine,Institute of Chinese Medical Sciences,University of Macau).The role of caveolin-1 in the biofate and efficacy of anti-tumor drugs and their nano-drug delivery systems[J].Acta Pharmaceutica Sinica B,2021,第4期
  • Yinqian Yang1,Yongjiu Lv1,Chengying Shen1,Tingting Shi1,Haisheng He1,Jianping Qi1,Xiaochun Dong1,Weili Zhao1,Yi Lu1,Wei Wu1,2(Key Laboratory of Smart Drug Delivery of MOE,School of Pharmacy,Fudan University;Center for Medical Research and Innovation,Shanghai Pudong Hospital,Fudan University Pudong Medical Center).In vivo dissolution of poorly water-soluble drugs:Proof of concept based on fluorescence bioimaging[J].Acta Pharmaceutica Sinica B,2021,第4期
  • Cláudia Pina Costa1,Jo?o Nuno Moreira2,3,José Manuel Sousa Lobo1,Ana Catarina Silva1,4(UCIBIO/REQUIMTE,Medtech,Laboratory of Pharmaceutical Technology,Department of Drug Sciences,Faculty of Pharmacy,University of Porto;CNC-Center for Neuroscience and Cell Biology,Center for Innovative Biomedicine and Biotechnology (CIBB),University of Coimbra,Faculty of Medicine (Pólo I);UC-University of Coimbra,CIBB,Faculty of Pharmacy,Pólo Das Ciências da Saúde;FP-ENAS (UFP Energy,Environment and Health Research Unit),CEBIMED (Biomedical Research Centre),Faculty of Health Sciences,University Fernando Pessoa).Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions:A current overview of in vivo studies[J].Acta Pharmaceutica Sinica B,2021,第4期
  • Jifen Zhang1,2,Clairissa D.Corpstein2,Tonglei Li2(College of Pharmaceutical Sciences,Southwest University;Department of Industrial and Physical Pharmacy,Purdue University).Intracellular uptake of nanocrystals:Probing with aggregation-induced emission of fluorescence and kinetic modeling[J].Acta Pharmaceutica Sinica B,2021,第4期
  • Yongchao Wang1,2,3,Jinjin Wang2,3,Dandan Zhu1,Yufei Wang2,3,Guangchao Qing2,3,Yuxuan Zhang2,3,Xiaoxuan Liu1,Xing-Jie Liang2,3(State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases,Center of Drug Discovery,Center of Advanced Pharmaceutics and Biomaterials,China Pharmaceutical University;Laboratory of Controllable Nanopharmaceuticals,Chinese Academy of Sciences (CAS) Center for Excellence in Nanoscience and CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety,National Center for Nanoscience and Technology;University of Chinese Academy of Sciences).Effect of physicochemical properties on in vivo fate of nanoparticle-based cancer immunotherapies[J].Acta Pharmaceutica Sinica B,2021,第4期
  • Baode Shen1,2,Chengying Shen1,Weifeng Zhu2,Hailong Yuan1(Department of Pharmacy,Air Force Medical Center,PLA;Key Lab of Modern Preparation of Traditional Chinese Medicine (TCM),Ministry of Education,Jiangxi University of TCM).The contribution of absorption of integral nanocrystals to enhancement of oral bioavailability of quercetin[J].Acta Pharmaceutica Sinica B,2021,第4期
  • Wenhao Wang1,Zhengwei Huang1,Yanbei Li1,Wenhua Wang1,Jiayu Shi1,Fangqin Fu2,Ying Huang2,Xin Pan1,Chuanbin Wu1(School of Pharmaceutical Sciences,Sun Yat-Sen University;College of Pharmacy,Jinan University).Impact of particle size and pH on protein corona formation of solid lipid nanoparticles:A proof-of-concept study[J].Acta Pharmaceutica Sinica B,2021,第4期
  • Jinrong Peng,Yao Xiao,Qian Yang,Qingya Liu,Yu Chen,Kun Shi,Ying Hao,Ruxia Han,Zhiyong Qian(State Key Laboratory of Biotherapy and Cancer Center,West China Hospital,Sichuan University and Collaborative Innovation Center of Biotherapy).Intracellular aggregation of peptide-reprogrammed small molecule nanoassemblies enhances cancer chemotherapy and combinatorial immunotherapy[J].Acta Pharmaceutica Sinica B,2021,第4期
  • Anan Yaghmur,Huiling Mu(Department of Pharmacy,Faculty of Health and Medical Sciences,University of Copenhagen).Recent advances in drug delivery applications of cubosomes, hexosomes, and solid lipid nanoparticles[J].Acta Pharmaceutica Sinica B,2021,第4期
  • Fei Xia1,Zhongjian Chen2,Quangang Zhu2,Jianping Qi1,Xiaochun Dong1,Weili Zhao1,Wei Wu1,Yi Lu1(Key Laboratory of Smart Drug Delivery of MOE,School of Pharmacy,Fudan University;Shanghai Skin Disease Hospital,Tongji University School of Medicine).Gastrointestinal lipolysis and trans-epithelial transport of SMEDDS via oral route[J].Acta Pharmaceutica Sinica B,2021,第4期
  • Xiangjun Meng1,2,Zhi Zhang1,Jin Tong1,Hui Sun1,John Paul Fawcett1,Jingkai Gu1,3(Research Center for Drug Metabolism,School of Life Sciences,Jilin University;School of Pharmaceutical Sciences,Tsinghua University;Beijing Institute of Drug Metabolism).The biological fate of the polymer nanocarrier material monomethoxy poly(ethylene glycol)-block-poly(D,L-lactic acid) in rat[J].Acta Pharmaceutica Sinica B,2021,第4期
  • Zibei Lin1,Long Xi1,Shaokui Chen1,Jinsong Tao1,Yan Wang2,Xin Chen1,Ping Li2,Zhenping Wang3,Ying Zheng1(State Key Laboratory of Quality Research in Chinese Medicine,Institute of Chinese Medical Sciences,University of Macau;Beijing Hospital of Traditional Chinese Medicine,Affliated with Capital Medical University;Department of Dermatology,School of Medicine,University of California).Uptake and traffcking of different sized PLGA nanoparticles by dendritic cells in imiquimod-induced psoriasis-like mice model[J].Acta Pharmaceutica Sinica B,2021,第4期
  • Ana L.Martínez-López1,Carlos J.González-Navarro2,Paula Aranaz2,José L.Vizmanos3,4,Juan M.Irache1(NANO-VAC Research Group,Department of Chemistry and Pharmaceutical Technology,School of Pharmacy and Nutrition,University of Navarra;Center for Nutrition Research,School of Pharmacy and Nutrition,University of Navarra;Department of Biochemistry & Genetics,School of Science,University of Navarra;Navarra Institute for Health Research (IdiSNA)).In vivo testing of mucus-permeating nanoparticles for oral insulin delivery using Caenorhabditis elegans as a model under hyperglycemic conditions[J].Acta Pharmaceutica Sinica B,2021,第4期
  • Samrat Mazumdar,Deepak Chitkara,Anupama Mittal(Department of Pharmacy,Birla Institute of Technology and Science (BITS-PILANI)).Exploration and insights into the cellular internalization and intracellular fate of amphiphilic polymeric nanocarriers[J].Acta Pharmaceutica Sinica B,2021,第4期
  • Wei Wu1,2,Tonglei Li3,Ying Zheng4(Key Laboratory of Smart Drug Delivery of MOE,School of Pharmacy,Fudan University;Center for Medical Research and Innovation,Shanghai Pudong Hospital,Fudan University Pudong Medical Center;Department of Industrial and Physical Pharmacy,College of Pharmacy,Purdue University;State Key Laboratory of Quality Research in Chinese Medicine,Institute of Chinese Medical Sciences,University of Macau).Editorial of Special Issue “The Biological Fate of Drug Nanocarriers”[J].Acta Pharmaceutica Sinica B,2021,第4期
首页 上一页 6 7 8 9 10 下一页 尾页 共有11页,转到 页

帮助 | 繁體中文 | 关于发现 | 联系我们

超星发现系统 Copyright©·powered by 超星

客服电话:4008236966